Peter C Morris MD

Obstetrics & Gynecology•Lincoln, NE

Gynecologic Oncology

Physician

Join to View Full Profile

4101 Tiger Lily RdSte 100Lincoln, NE 68516
Phone+1 402-420-7000
Fax+1 402-420-6969

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1990 - 1992
University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 1985 - 1988
University of New Mexico School of MedicineInternship, Transitional Year, 1983 - 1984
University of Texas Southwestern Medical SchoolClass of 1983

Certifications & Licensure

NE State Medical License 1992 - 2026
IA State Medical License 1990 - 2007
TX State Medical License 1983 - 2005
NC State Medical License 1985 - 1992
OK State Medical License 1986 - 1991
NM State Medical License 1984 - 1988
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Start of enrollment: 2013 Jun 05
Active, not recruiting
Not Applicable
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Join now to see all

Publications & Presentations

PubMed

76 citations
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve
The Lancet. Oncology. 2020-12-01
10 citations
Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial
David B. Engle, Joseph P. Connor, Peter C. Morris, David Bender, Koen De Geest
Archives of Gynecology and Obstetrics. 2012-05-09
44 citations
Nonbacterial Thrombotic Endocarditis with Recurrent Embolic Events as Manifestation of Ovarian Neoplasm
Arash Aryana, Dennis J. Esterbrooks, Peter C. Morris
Journal of General Internal Medicine. 2006-12-01

Press Mentions

Bryan Health & Cancer Partners of Nebraska Bring New Cancer Specialty to LincolnJanuary 14th, 2022
Researchers Find Gene to Make Barley ‘Drought-Proof’September 2nd, 2019